South & Central America Poultry Vaccines Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2031 - Regional Analysis - by Type (Broiler and Layer), Technology (Live Attenuated Vaccines, Inactivated Vaccines, and Recombinant Vaccines), Dosage Form (Liquid Vaccines, Freeze-Dried Vaccines, and Dust/Powdered Vaccines), Disease (Avian Influenza, Salmonellosis, Mareks Disease, Infectious Bronchitis (IB), Infectious Bursal Disease (IBD), Newcastle Disease, and Others), Route Of Administration (Drinking water (D/W), Intramuscular (I/M), Subcutaneous (S/C), and Others), and End User (Poultry Farms, Veterinary Hospitals, and Poultry Vaccination Centers and Clinics)

No. of Pages: 111    |    Report Code: TIPRE00023752    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
South & Central America Poultry Vaccines Market

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. South & Central America Poultry Vaccines Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. South & Central America Poultry Vaccines Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Rising Prevalence of Poultry Diseases
5.2 Market Opportunities
  • 5.2.1 Government Support for Mass Vaccination Drives and Innovative Schemes
5.3 Future Trends
  • 5.3.1 Advancements in vectored and combination vaccines
5.4 Impact of Drivers and Restraints

6. South & Central America Poultry Vaccines Market Regional Analysis

6.1 South & Central America Poultry Vaccines Market Overview
6.2 South & Central America Poultry Vaccines Market Revenue 2019-2028 (US$ Million)
6.3 South & Central America Poultry Vaccines Market Forecast Analysis

7. South & Central America Poultry Vaccines Market Analysis – by Type

7.1 Broiler
  • 7.1.1 Overview
  • 7.1.2 Broiler: South & Central America Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Layer
  • 7.2.1 Overview
  • 7.2.2 Layer: South & Central America Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Breeder
  • 7.3.1 Overview
  • 7.3.2 Breeder: South & Central America Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)

8. South & Central America Poultry Vaccines Market Analysis – by Technology

8.1 Live Attenuated Vaccines
  • 8.1.1 Overview
  • 8.1.2 Live Attenuated Vaccines: South & Central America Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Inactivated Vaccines
  • 8.2.1 Overview
  • 8.2.2 Inactivated Vaccines: South & Central America Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Recombinant Vaccines
  • 8.3.1 Overview
  • 8.3.2 Recombinant Vaccines: South & Central America Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

9. South & Central America Poultry Vaccines Market Analysis – by Dosage Form

9.1 Liquid vaccines
  • 9.1.1 Overview
  • 9.1.2 Recombinant Vaccines: South & Central America Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Freeze-Dried Vaccines
  • 9.2.1 Overview
  • 9.2.2 Recombinant Vaccines: South & Central America Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Dust/Powdered Vaccines
  • 9.3.1 Overview
  • 9.3.2 Recombinant Vaccines: South & Central America Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

10. South & Central America Poultry Vaccines Market – South and Central America Analysis

10.1 South and Central America
  • 10.1.1 South & Central America Poultry Vaccines Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 10.1.1.1 South & Central America Poultry Vaccines Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 Brazil: South & Central America Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 Brazil: South & Central America Poultry Vaccines Market Breakdown, by Type
    • 10.1.1.1.2 Brazil: South & Central America Poultry Vaccines Market Breakdown, by Technology
    • 10.1.1.1.3 Brazil: South & Central America Poultry Vaccines Market Breakdown, by Dosage Form
  • 10.1.1.2 Argentina: South & Central America Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Argentina: South & Central America Poultry Vaccines Market Breakdown, by Type
    • 10.1.1.2.2 Argentina: South & Central America Poultry Vaccines Market Breakdown, by Technology
    • 10.1.1.2.3 Argentina: South & Central America Poultry Vaccines Market Breakdown, by Dosage Form
  • 10.1.1.3 Rest of South and Central America : South & Central America Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 Rest of South and Central America : South & Central America Poultry Vaccines Market Breakdown, by Type
    • 10.1.1.3.2 Rest of South and Central America : South & Central America Poultry Vaccines Market Breakdown, by Technology
    • 10.1.1.3.3 Rest of South and Central America : South & Central America Poultry Vaccines Market Breakdown, by Dosage Form

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. South & Central America Poultry Vaccines Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Boehringer Ingelheim Intrnational GmbH.
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Zoitis Inc.
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Ceya Santae Animale.
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 BIOVAC.
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 PHIBRO ANIMAL HEALTH CORPORATION.
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Hester Biosciences Limited.
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Dechra Pharmaceutical Plc.
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Elanco.
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Merck Animal Health
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - South & Central America Poultry Vaccines Market

  1. Boehringer Ingelheim International GmbH.
  2. Zoetis Inc.
  3. Phibro Animal Health Corp.
  4. Dechra Pharmaceuticals PLC.
  5. Elanco Animal Health Inc.
  6. Merck KGaA.
  7. Ceva.
  8. Vaccinova AB.